-->
In-vitro toxicology testing market was valued at US$ 26.00 billion in 2024 and is projected to hit the market valuation of US$ 57.55 billion by 2033 at a CAGR of 9.23% during the forecast period 2025–2033.
India mental health market was valued at US$ 6.90 billion in 2023 and is projected to hit the market valuation of US$ 62.86 billion by 2032 at a CAGR of 28.16% during the forecast period 2024–2032.
Japan pet diagnostics market was valued at US$ 169.65 million in 2023 and is projected to hit the market valuation of US$ 301.66 million by 2032 at a CAGR of 6.78% during the forecast period 2024–2032.
Europe medical cannabis oil market was valued at US$ 905.56 million in 2023 and is projected to hit the market valuation of US$ 2,395.83 million by 2032 at a CAGR of 12.8% during the forecast period 2024–2032.
Global D-dimer testing market was valued at US$ 1,500.27 million in 2023 and is projected to hit the market valuation of US$ 2,269.31 million by 2032, at a CAGR of 4.79% during the forecast period 2024–2032.
Chile immunohematology market was valued at US$ 11.59 million in 2023 and is projected to hit the market valuation of US$ 17.32 million by 2032 at a CAGR of 4.61% during the forecast period 2024–2032.
Vietnam OTC consumer health products market was valued at US$ 2,539.68 million in 2023 and is projected to hit the market valuation of US$ 5,253.69 million by 2032 at a CAGR of 8.67% during the forecast period 2024–2032.
The global CAR T-cell therapy market is set for substantial expansion, projected to exceed USD 27.5 billion by 2033, up from USD 2.7 billion in 2025, reflecting a robust CAGR of 26.2% from 2025 to 2033.
India nutritional supplements market was valued at U$ 11.85 billion in 2023 and is projected to hit the market valuation of US$ 28.70 billion by 2032 at a CAGR of 10.7% during the forecast period 2024–2032.